Medicinal cannabis expert Simon Langelier joined the board of Imperial Brands as a non-executive director this week
As smokers quit the habit, British tobacco giant Imperial Brands is seemingly looking towards another plant to bring in the billions: cannabis.
Imperial, which dropped the word tobacco from its name eighteen months ago, has hired medicinal cannabis expert Simon Langelier to join its board as a non-executive director.
Mr Langelier, who spent thirty years at rival tobacco firm Philip Morris, is also chairman of Canadian firm PharmaCielo which supplies medicinal cannabis oil extracts. That experience could be valuable in helping Imperial maximise opportunities from a wave of marijuana legislation spreading across the US.
READ THE FULL STORY BELOW